• R Gennari, J W Alexander, T Pyles, S Hartmann, and C K Ogle.
• Department of Surgery, University of Cincinnati, Ohio.
• Arch Surg Chicago. 1994 Nov 1; 129 (11): 1191-7.

BackgroundRecent studies have shown that interleukin-6 (IL-6) is involved in the systemic changes that are associated with infection and tissue injury and that there is a correlation between high levels of IL-6 and poor outcome during several pathologic conditions.ObjectiveThe effects of antimurine IL-6 antibody on survival and host defense were studied in a clinically relevant model of infection.MethodsBalb/c mice were treated with 10 micrograms of antimurine interleukin-6, a nonspecific mouse IgG, or placebo 1 hour before they underwent bacterial challenge by gavage of 10(10) Escherichia coli and burn injury. Survival and the extent of translocation of E coli were determined as well as the correlation between the IL-6 levels and survival times.ResultsSurvival after burn and gavage was 90% in animals treated with antimurine interleukin-6 vs 50% in animals treated with nonspecific IgG and 30% in saline-treated controls. A significant correlation between the levels of IL-6 and survival time was observed. Less translocation and better killing of bacteria were observed in the tissues of animals treated with antimurine interleukin-6.ConclusionsInterleukin-6 appears to play a major role in both the intensity of translocation of E coli from the intestine following burn injury and the host's ability to kill translocated organisms. Improved outcome was associated with a reduction of IL-6 levels by anti-IL-6 antibody.

19 keywords...

hide…